Global Boronate Affinity Tests Market Analysis 2024 – Estimated Market Size And Key Drivers

The Boronate Affinity Tests Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Boronate Affinity Tests Market:
https://www.thebusinessresearchcompany.com/report/boronate-affinity-tests-global-market-report

According to The Business Research Company’s Boronate Affinity Tests Global Market Report 2024, The boronate affinity tests market size has grown strongly in recent years. It will grow from $3.15 billion in 2023 to $3.47 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increased research and development, a rising incidence of chronic diseases, a growing biotechnology industry, growing government and academic research funding, increasing demand for personalized medicine, and increased availability of advanced equipment.

The boronate affinity tests market size is expected to see rapid growth in the next few years. It will grow to $5.08 billion in 2028 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to growing adoption in clinical diagnostics, rising awareness and education, expansion into emerging markets, strategic collaborations and partnerships, increasing prevalence of metabolic disorders, and a growing focus on early disease detection. Major trends in the forecast period include integration with digital health, automation and high-throughput screening, expansion in clinical applications, advancements in sample preparation, an increased focus on glycomics, the development of new reagents and kits, and regulatory advancements.

The increasing diabetic population is expected to propel the growth of the boronate affinity tests market going forward. Diabetes is a chronic medical condition characterized by high blood glucose levels due to the body’s inability to produce or effectively use insulin. The diabetes cases are rising due to poor diet, especially high consumption of processed foods and sugary drinks, and sedentary lifestyles characterized by minimal physical activity. Moreover, the aging population and family history of diabetes increase the risk, indicating a genetic predisposition. Boronate affinity tests are used in diabetes management to accurately measure glycated proteins, providing a reliable indicator of long-term blood glucose control. For instance, in June 2023, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, global diabetes cases are projected to increase from 529 million in 2021 to 1.3 billion by 2050. Therefore, the increasing diabetic population will drive the growth of the boronate affinity tests market.

<h4 class=reporthtag>Rising Focus On Personalized Medicine Drives Growth In Boronate Affinity Tests Market</h4>

The increasing focus on personalized medicine is expected to propel the growth of the boronate affinity tests market going forward. Personalized medicine customizes healthcare using individual genetic, environmental, and lifestyle information to optimize treatment outcomes. The growing emphasis on personalized medicine is fueled by a better understanding of genetic variations and their health impacts, as well as advancements in diagnostic tools and progress in data analysis, bioinformatics, and precision medicine technologies. Boronate affinity tests in personalized medicine are used for precise monitoring of glycation levels in patients, aiding in tailored diabetes management and treatment plans. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Moreover, it includes seven drugs tailored for cancer treatment and three targeting different diseases and conditions. Therefore, the increasing focus on personalized medicine will drive the growth of the boronate affinity tests market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18266&type=smp

The boronate affinity tests market covered in this report is segmented –

1) By Product Type: Test Kits, Instruments, Consumables
2) By Technology: Fluorescence Based Tests, Colorimetric Assays, Electrochemical Methods
3) By Indication: Type 1 Diabetes, Type 2 Diabetes
4) By End User: Hospitals And Clinics, Diagnostics Labarotories, Research Institutes, Pharmaceutical And Biotechnology Companies

The boronate affinity tests market report table of contents includes:

1. Executive Summary
2. Boronate Affinity Tests Market Characteristics
3. Boronate Affinity Tests Market Trends And Strategies
4. Boronate Affinity Tests Market – Macro Economic Scenario
5. Global Boronate Affinity Tests Market Size and Growth
.
.
.
32. Global Boronate Affinity Tests Market Competitive Benchmarking
33. Global Boronate Affinity Tests Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Boronate Affinity Tests Market
35. Boronate Affinity Tests Market Future Outlook and Potential Analysis
36. Appendix